The Short Answer for April-May 2026
Yes, you can still buy compounded tirzepatide in spring 2026, but the path is narrower than it was a year ago. After the FDA declared the tirzepatide shortage resolved in late 2024, the window for routine 503A and 503B compounding of tirzepatide closed. What's left is personalized compounding: a prescriber must document a clinical need that requires a modification from the FDA-approved drug, and a licensed pharmacy dispenses that specific formulation for an individual patient.
Several reputable telehealth platforms continue to work within that framework in April and May 2026, typically pairing tirzepatide with additional components (B12, glycine, or dose-titration adjustments) that make the compound distinct from commercial Zepbound or Mounjaro. Pricing for a monthly supply generally ranges from roughly $199 to $399, depending on dose and platform.
Skip ahead: Our top-rated pharmacy for April 2026
Synergy Rx pairs U.S.-based licensed prescribers with a 503A compounding pharmacy network. No insurance needed, telehealth visit included, shipped nationwide.
Get started with Synergy Rx →What Changed: The 2024-2025 Regulatory Shift
From 2022 through most of 2024, tirzepatide was on the FDA drug shortage list, which unlocked broad compounding authority under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. Dozens of telehealth companies jumped in, and patients saw monthly prices as low as $149.
In October 2024, the FDA declared the shortage resolved. After a transition period that wrapped up in early 2025, 503B outsourcing facilities were required to stop making tirzepatide copies. 503A pharmacies retained a narrower exception: they can compound a personalized version for an individual patient when the prescribing clinician documents a specific clinical reason the commercial product doesn't meet that patient's needs.
This is the framework under which April-May 2026 compounded tirzepatide is being dispensed. Pharmacies and telehealth platforms that have adapted to this workflow are still operating. Those that kept mass-producing generic tirzepatide copies have either shut down, pivoted, or are facing enforcement action.
Who's Still Shipping in April-May 2026
Based on publicly available program pages, state board of pharmacy filings, and our own test orders placed in the first week of April 2026, these platforms are currently dispensing compounded tirzepatide formulations:
Synergy Rx
Telehealth intake, U.S.-licensed prescribers, partnered 503A compounding pharmacies. Offers personalized tirzepatide formulations with clinical documentation built into the workflow. Monthly pricing starts around $249 for lower doses. Same-day prescriber review in most states.
Visit Synergy Rx →SHED
Metabolic health platform with a dedicated GLP-1 track. Includes asynchronous provider visits, lab ordering, and shipped compounded formulations via partner pharmacies. Strong program for patients who want structured check-ins during titration.
Visit SHED →Yucca Health
Lower-priced entry point into compounded tirzepatide, with transparent monthly pricing and no hidden consultation fees. Good fit for patients paying entirely out of pocket who want predictable cost.
Visit Yucca Health →April-May 2026 Pricing Bands
Prices below reflect what we're seeing on public landing pages as of early April 2026. Actual cost depends on dose, titration schedule, and whether lab work is included.
| Tier | Monthly Range | What's Included |
|---|---|---|
| Entry / low dose (2.5-5 mg) | $199 - $279 | Telehealth visit, compounded vial, syringes |
| Mid dose (7.5-10 mg) | $279 - $349 | Same as above, larger volume |
| High dose (12.5-15 mg) | $329 - $399 | Same as above, may require additional labs |
| Premium / concierge | $399 - $549 | Dedicated nurse line, weekly check-ins, labs included |
How to Actually Place an Order in April 2026
- Complete a medical intake. This is a real clinical questionnaire covering BMI, medical history, current medications, and weight loss goals. Expect it to take 10-15 minutes.
- Upload a recent weight / vitals, or schedule a video visit. Most reputable platforms require at least one of these before a prescriber will sign off.
- Prescriber review. A U.S.-licensed clinician reviews your intake and determines whether compounded tirzepatide is appropriate. If so, they document the clinical reason for a personalized formulation.
- Pharmacy dispensing. The partnered 503A pharmacy receives the prescription, compounds the specific formulation ordered, and ships directly to your address (signature required in most states).
- Follow-up cadence. Plan for monthly or quarterly check-ins with the prescriber to adjust dose and monitor side effects.
Want the lowest out-of-pocket cost?
Yucca Health's transparent monthly pricing makes them a strong fit for self-pay patients. See current Yucca Health pricing →
Red Flags to Avoid This Spring
- No prescriber visit. If a site ships tirzepatide without any clinical review, that's not legal compounding. Walk away.
- Foreign shipping origin. Tirzepatide arriving from overseas is almost certainly unapproved and possibly not what the label says it is.
- "FDA-approved compound" language. Compounded drugs are not FDA-approved as such. Any site using that phrase is either misinformed or misleading.
- No pharmacy name listed. A legitimate platform will tell you which licensed 503A pharmacy is dispensing your order. If they won't, there's a reason.
- Pricing wildly below market. See the warning box above.
What About Brand-Name Zepbound or Mounjaro?
If compounding isn't the right fit for you, or if your insurance might cover the brand-name product, it's worth getting a quick telehealth consult with a service that prescribes FDA-approved brand-name medications and can route the prescription to your pharmacy or handle prior authorization.
Prefer brand-name Zepbound or Mounjaro?
Sesame Care prescribes FDA-approved brand-name medications through their online weight loss program, with transparent flat-fee telehealth pricing. Start with Sesame Care →
Frequently Asked Questions
Is compounded tirzepatide still legal in April 2026?
Yes, when dispensed by a licensed 503A pharmacy under a valid prescription for an individual patient with documented clinical need for a personalized formulation. What's no longer legal is large-scale 503B production of generic tirzepatide copies.
Why is my monthly price higher than it was in 2024?
The 503B bulk-production channel closed, which removed the cheapest supply source. Personalized 503A compounding involves more labor per order, which is reflected in pricing.
Do I need insurance?
No. All the platforms covered in this guide operate cash-pay. Most patients pay out of pocket regardless of insurance status because compounded medications are rarely covered.
How fast can I get a shipment in April-May 2026?
From completed intake to delivery, most reputable platforms land in the 3-7 business day window. Some offer 24-hour prescriber review and 2-day shipping as a premium option.
Can I use my HSA or FSA?
Usually yes for telehealth visit fees, and sometimes for the compounded medication itself if your plan treats it as a covered prescription expense. Check with your plan administrator.
Bottom Line for April-May 2026
Buying compounded tirzepatide is still possible and still legal this spring, as long as you're working with a licensed U.S. prescriber and a 503A compounding pharmacy under a personalized prescription. The era of cheap, unlimited generic tirzepatide copies is over, but reputable telehealth platforms have adapted and continue to serve patients who need this medication and can't access or afford the brand-name alternatives.
For most patients in spring 2026, the fastest legitimate path is a telehealth intake with a platform like Synergy Rx or SHED, with a monthly budget of roughly $249-$349 covering both the visit and the shipped medication.
Ready to get started?
Our top-rated April 2026 pick, Synergy Rx, can have you evaluated by a U.S.-licensed prescriber today with shipment typically within a week.
Start with Synergy Rx →